Ciro P. Romano

Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Visible Light-Promoted Cascade Cyclization/Allylation of 2-Allyloxyaryl Sulfonium Salts with Morita-Baylis-Hillman Acetates.

Visible Light-Promoted Cascade Cyclization/Allylation of 2-Allyloxyaryl Sulfonium Salts with Morita-Baylis-Hillman Acetates.

Journal: Organic letters

Published: March 16, 2026

Mast Cells and Substance P: Neuroinflammatory Loops at the Molecular and Translational Clinical Levels.

Mast Cells and Substance P: Neuroinflammatory Loops at the Molecular and Translational Clinical Levels.

Journal: Biomolecules

Published: January 31, 2026

Role of Mast Cells and Neuroinflammation in Neuropsychiatric Disorders of the Developmental Period.

Role of Mast Cells and Neuroinflammation in Neuropsychiatric Disorders of the Developmental Period.

Journal: Biomolecules

Published: January 31, 2026

Immunosenescence and Allergy: Molecular and Cellular Links Between Inflammaging, Neuro-Immune Aging, and Response to Biologic Therapies.

Immunosenescence and Allergy: Molecular and Cellular Links Between Inflammaging, Neuro-Immune Aging, and Response to Biologic Therapies.

Journal: International journal of molecular sciences

Published: November 30, 2025

Alkoxysulfonium Salts Unlock Access to New Aryl Sulfonium Salts for Cross-Coupling.

Alkoxysulfonium Salts Unlock Access to New Aryl Sulfonium Salts for Cross-Coupling.

Journal: Angewandte Chemie (International ed. in English)

Published: November 16, 2025

Computational study of the effect of Lewis base additives and molecular spin state in SmI2-chemistry.

Computational study of the effect of Lewis base additives and molecular spin state in SmI2-chemistry.

Journal: Chemical science

Published: October 28, 2025

GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study.

GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study.

Journal: International journal of molecular sciences

Published: September 15, 2025

Contemporary Strategies in SmI2 Catalysis: A Reagent Reborn.

Contemporary Strategies in SmI2 Catalysis: A Reagent Reborn.

Journal: Angewandte Chemie (International ed. in English)

Published: September 08, 2025

Intra-plaque vascularization assessed in contrast-enhanced ultrasound predicts cardiovascular events in type 2 diabetes with no significant carotid atherosclerotic stenosis: a prospective study with therapeutic implications for SGLT2 inhibitor use.

Intra-plaque vascularization assessed in contrast-enhanced ultrasound predicts cardiovascular events in type 2 diabetes with no significant carotid atherosclerotic stenosis: a prospective study with therapeutic implications for SGLT2 inhibitor use.

Journal: European heart journal. Imaging methods and practice

Published: August 21, 2025

Rheumatoid Arthritis and Osteoporosis as Prototypes of Immunosenescence in Osteoimmunology: Molecular Pathways of Inflammaging and Targeted Therapies.

Rheumatoid Arthritis and Osteoporosis as Prototypes of Immunosenescence in Osteoimmunology: Molecular Pathways of Inflammaging and Targeted Therapies.

Journal: International journal of molecular sciences

Published: August 08, 2025

Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study.

Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study.

Journal: Diabetes research and clinical practice

Published: June 26, 2025

Vericiguat for endothelial dysfunction and CRT response in non-responders: the VERCET prospective observational study.

Vericiguat for endothelial dysfunction and CRT response in non-responders: the VERCET prospective observational study.

Journal: BMC medicine

Published: June 11, 2025

Showing 1-12 of 72

Last Updated: 09/26/2026